Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
3.430
+0.050 (1.48%)
Nov 21, 2025, 1:19 PM EST - Market open
AVR Market Cap
AVR has a market cap or net worth of $139.24 million as of November 21, 2025. Its market cap has decreased by -11.51% in one year.
Market Cap
139.24M
Enterprise Value
132.33M
1-Year Change
-11.51%
Ranking
Category
Stock Price
$3.43
Market Cap Chart
Since the IPO on October 23, 2017, AVR's market cap has increased from $49.67M to $139.24M, an increase of 180.33%. That is a compound annual growth rate of 13.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 144.03M | -21.69% |
| Dec 31, 2024 | 183.94M | -20.93% |
| Dec 29, 2023 | 232.62M | 10.90% |
| Dec 30, 2022 | 209.76M | 100.65% |
| Dec 31, 2021 | 104.54M | 525.78% |
| Dec 22, 2020 | 16.71M | -59.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 934.14B |
| Johnson & Johnson | 489.26B |
| AbbVie | 405.53B |
| UnitedHealth Group | 282.20B |
| AstraZeneca | 277.11B |
| Novartis AG | 239.24B |
| Merck & Co. | 235.72B |
| Abbott Laboratories | 215.57B |